The Deepest Field Since 1967, and the 37-Year-Old at Its Center

There are six pitchers in the National League with an ERA below 2.00 and at least 50 innings pitched. The last time that sentence was true, it was 1967, Bob Gibson was about to post a number so absurd the league lowered the mound in response, and baseball still played in two leagues without a designated hitter. The NL hasn't seen this kind of pitching density in fifty-nine years.

Chris Sale is one of the six. He may not be the favorite.

That last fact is the most interesting thing about his season.

The Case in Eleven Starts

Sale's 2026 line through Wednesday: 8-3, 2.01 ERA, 0.94 WHIP, 80 strikeouts in 67 innings, a .185 opponent batting average, and a 174 ERA+. If those numbers feel familiar, they should. His 2024 Cy Young campaign finished at 2.38 ERA, 1.01 WHIP, .220 opponent batting average, and the same 174 ERA+.

The 2026 version is better. Not by the dramatic margins that make for easy arguments, but by the small, structural ones that separate excellent from elite. The ERA is 37 points lower. The WHIP is seven hundredths tighter. Opponents are hitting 35 points less against him. The strikeout rate has dropped slightly -- 10.75 K/9 this year against 11.40 in 2024 -- but that trade-off tells you something about what Sale has become: a pitcher who has decided that getting outs efficiently matters more than getting them violently.

His WHIP has been below 1.00 for the first time since 2018. Eight years is a long time in any profession. In pitching years, it is a geological era.

The Field

The problem with building a Cy Young case in May is that everyone else is building one too. In a normal year, Sale's numbers would make him the clear frontrunner. This is not a normal year.

Cristopher Sanchez in Philadelphia has a 1.46 ERA and 44.2 consecutive scoreless innings. He is the betting favorite at +145, and the odds reflect reality, not recency bias. Tobias Misiorowski in Milwaukee carries a 1.83 ERA with 100 strikeouts. Shohei Ohtani, whose name distorts any conversation it enters, sits alongside Sale at +750. There are others. The depth of this field is historically unusual, and any honest accounting of Sale's candidacy must begin by acknowledging that he is competing in the most talented NL pitching year since before the mound was lowered.

Sale knows this. He has been pitching in the major leagues since 2010. He has seen eras come and go. He understands, in a way that younger pitchers cannot yet, that the award is not given for the best version of yourself. It is given for the best version relative to everyone else.

What Changed Between Trophies

The 2025 season sits between the two campaigns like a parenthetical. Sale went 7-5 with a 2.58 ERA in 20 starts before a fractured rib cage sent him to the injured list on June 21. He missed 62 games. The rib healed. What returned in 2026 was not the same pitcher who left.

The difference is control, and control is not the same as command. Command is knowing where the ball should go. Control is eliminating the pitches where it doesn't. Sale's sub-1.00 WHIP is the statistical fingerprint of a pitcher who has stopped donating baserunners. In 2024, he was brilliant despite occasional generosity. In 2026, the generosity is gone.

There's a version of this season where the fractured rib was the thing that taught him to throw less. Where the forced reduction in workload recalibrated his relationship with effort. Where the injury that cost him half a season bought him another Cy Young. Baseball is full of these paradoxes, and Sale has been playing long enough to appreciate the irony.

The Historical Rarity

Sale turned 37 in March. Back-to-back Cy Young awards at this age would place him in a fraternity with exactly three members: Greg Maddux, Randy Johnson, and Roger Clemens. Those are not merely good pitchers. They are the names etched into the architecture of the sport. Maddux won his four consecutive Cy Youngs between ages 27 and 31. Johnson won four straight from ages 35 to 38. Clemens won at 35 and 38, though not consecutively.

Sale's path would be closest to Johnson's -- the late-career left-hander whose stuff evolved from overpowering to unanswerable. Johnson at 37 threw 260 innings with a 2.49 ERA. Sale at 37 is on pace for roughly 180 innings at 2.01. The workload is smaller, but the efficiency per inning is comparable. The game has changed its expectations of starter volume. What hasn't changed is the rarity of a pitcher improving his precision at an age when most are managing decline.

Baseball has a long memory, and the record books suggest that pitchers who win Cy Youngs past 36 are not having career years. They are having the years their careers were always building toward.

The Honest Assessment

Sale's 150th career win came on April 26. He has 153 now, a number that matters more for its trajectory than its total. His 2,659 career strikeouts rank 28th all-time and seventh among left-handers -- he passed Tom Glavine and Chuck Finley this season, and is on pace to reach 2,700 by mid-July. These are Hall of Fame peripherals accumulating around a pitcher who is still, demonstrably, getting better at the thing that matters most.

Wednesday at Fenway was not his sharpest outing: 5 innings, 6 hits, 2 earned runs, 3 walks, 8 strikeouts. The win pushed his record against the Red Sox to 3-0 since the trade, but the line was thicker than his season averages in every category. His May 20 start in Miami -- 7 innings, zero walks -- is the truer portrait of the 2026 Sale.

The numbers tell a story, but not the one you'd expect from a reigning Cy Young winner at 37. The story isn't decline managed or peak recaptured. It is refinement. Sale is pitching better than his trophy season, in a year when pitching better might not be enough, at an age when the act itself is the achievement. The field is the deepest it has been since 1967. He is building his case at its center, one efficient outing at a time, and the outcome is genuinely uncertain.

That uncertainty is the compliment.